Insiders who reported open-market trades in the last 12 months at the companies Thomas Malley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
John F. Paolini - $8.00M in KNSA purchases and sales in the last 12 months
Mark Ragosa - $3.78M in KNSA purchases and sales in the last 12 months
Michael R. Megna - $2.64M in KNSA purchases and sales in the last 12 months
Troy Edward Wilson - $2.35M in KURA purchases and sales in the last 12 months
Barry D. Quart - $1.85M in KNSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Thomas Malley is a corporate insider of Kura Oncology, Inc. (KURA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thomas Malley last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 4 filings going back to 2025.
Has Thomas Malley been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($5.86M) across all tracked filings.
Thomas Malley files SEC Form 4 reports at Kura Oncology, Inc. (KURA). 4 SEC Form 4 filings on record going back to 2025, most recently on 4 June 2026. Most recent open-market trade: sold $2.59M of KNSA on 12 August 2025. Lifetime open-market sales: $5.86M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Thomas Malley.
InsiderAlpha's records for Thomas Malley go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
